Literature DB >> 20696672

Cardiac defects contribute to the pathology of spinal muscular atrophy models.

Monir Shababi1, Javad Habibi, Hsiao T Yang, Spencer M Vale, Will A Sewell, Christian L Lorson.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive disorder, which is the leading genetic cause of infantile death. SMA is the most common inherited motor neuron disease and occurs in approximately 1:6000 live births. The gene responsible for SMA is called Survival Motor Neuron-1 (SMN1). Interestingly, a human-specific copy gene is present on the same region of chromosome 5q, called SMN2. Motor neurons are the primary tissue affected in SMA. Although it is clear that SMA is a neurodegenerative disease, there are clinical reports that suggest that other tissues contribute to the overall phenotype, especially in the most severe forms of the disease. In severe SMA cases, a growing number of congenital heart defects have been identified upon autopsy. The most common defect is a developmental defect referred to as hypoplastic left heart. The purpose of this report is to determine whether cardiac tissue is altered in SMA models and whether this could contribute to SMA pathogenesis. Here we identified early-stage developmental defects in a severe model of SMA. Additionally, pathological responses including fibrosis and oxidative stress markers were observed shortly after birth in a less severe model of disease. Similarly, functional differences were detected between wild-type and early-stage SMA animals. Collectively, this work demonstrates the importance of cardiac development and function in these severe models of SMA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696672     DOI: 10.1093/hmg/ddq329

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  100 in total

1.  Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction.

Authors:  Rocky G Gogliotti; Katharina A Quinlan; Courtenay B Barlow; Christopher R Heier; C J Heckman; Christine J Didonato
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

2.  The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.

Authors:  Matthew E R Butchbach; Jasbir Singh; Mark E Gurney; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2014-03-25       Impact factor: 5.330

3.  Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Authors:  Nimrod Miller; Zhihua Feng; Brittany M Edens; Ben Yang; Han Shi; Christie C Sze; Benjamin Taige Hong; Susan C Su; Jorge A Cantu; Jacek Topczewski; Thomas O Crawford; Chien-Ping Ko; Charlotte J Sumner; Long Ma; Yong-Chao Ma
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

4.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

5.  Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production.

Authors:  Jered V McGivern; Teresa N Patitucci; Joshua A Nord; Marie-Elizabeth A Barabas; Cheryl L Stucky; Allison D Ebert
Journal:  Glia       Date:  2013-07-10       Impact factor: 7.452

6.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

Review 7.  Developing therapies for spinal muscular atrophy.

Authors:  Mary H Wertz; Mustafa Sahin
Journal:  Ann N Y Acad Sci       Date:  2015-07-14       Impact factor: 5.691

Review 8.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

9.  Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.

Authors:  Shingo Kariya; Teresa Obis; Caterina Garone; Turgay Akay; Fusako Sera; Shinichi Iwata; Shunichi Homma; Umrao R Monani
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.

Authors:  Chitra C Iyer; Vicki L McGovern; Dawnne O Wise; David J Glass; Arthur H M Burghes
Journal:  Neuromuscul Disord       Date:  2014-02-25       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.